SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-09-256342
Filing Date
2009-12-21
Accepted
2009-12-21 06:15:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ds3a.htm S-3/A 185906
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2117
3 GRAPHIC g13487cov_pg001.jpg GRAPHIC 3767
  Complete submission text file 0001193125-09-256342.txt   194749
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-163479 | Film No.: 091251404
SIC: 2834 Pharmaceutical Preparations